UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 129

Sortiert nach

Is mesalazine treatment effective in the prevention of diverticulitis? A review

European review for medical and pharmacological sciences, 2020-08, Vol.24 (15), p.8164

2020

Link zum Volltext

Verfügbarkeit prüfen

Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

Annals of the rheumatic diseases, 2004-12, Vol.63 (12), p.1664-1669

2004

Link zum Volltext

Verfügbarkeit prüfen

P.09.11 ASSOCIATION BETWEEN COLORECTAL POLYPS AND COLONIC DIVERTICULOSIS

Digestive and liver disease, 2016-02, Vol.48, p.e175-e175

2016

Link zum Volltext

Verfügbarkeit prüfen

The dyspeptic macrophage 30 years later: An update in the pathogenesis of Crohn's disease

Digestive and liver disease, 2009-02, Vol.41 (2), p.166-168

2009

Link zum Volltext

Verfügbarkeit prüfen

Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation

European review for medical and pharmacological sciences, 2012-10, Vol.16 (11), p.1484

2012

Link zum Volltext

Verfügbarkeit prüfen

Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis

Gut, 2000-09, Vol.47 (3), p.410-414

2000

Link zum Volltext

Verfügbarkeit prüfen

P.06.6 SUBTYPES OF CHRONIC GASTRITIS IN PATIENTS WITH COELIAC DISEASE BEFORE AND AFTER GLUTEN-FREE DIET

Digestive and liver disease, 2016-02, Vol.48, p.e155-e155

2016

Link zum Volltext

Verfügbarkeit prüfen

P.03.10 FUNCTIONAL DYSPEPSIA: IS DUODENAL BIOPSY WORTHWHILE?

Digestive and liver disease, 2014-03, Vol.46, p.S63-S63

2014

Link zum Volltext

Verfügbarkeit prüfen

Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis

Digestive and liver disease, 2005-02, Vol.37 (2), p.92-96

2005

Link zum Volltext

Verfügbarkeit prüfen

Mesalazine vanishing time from rectal mucosa following its topical administration

Journal of Crohn's and colitis, 2010-02, Vol.4 (1), p.102-105

2010

Link zum Volltext

Verfügbarkeit prüfen

P.05.12 COLONIC MUCOSAL ORGAN CULTURE: ITS OPPORTUNISTIC USE TO DETECT CELIAC DISEASE

Digestive and liver disease, 2013-03, Vol.45, p.S122-S123

2013

Link zum Volltext

Verfügbarkeit prüfen

Short‐chain fatty acid topical treatment in distal ulcerative colitis

Alimentary pharmacology & therapeutics, 1995-06, Vol.9 (3), p.309-313

1995

Link zum Volltext

Verfügbarkeit prüfen

AF.41 THE PROGNOSTIC VALUE OF ENDOSCOPIC MAYO SCORE 0 VERSUS 1 IN PATIENTS WITH ULCERATIVE COLITIS IN STEROID-FREE CLINICAL REMISSION: A SYSTEMATIC REVIEW AND METAANALYSIS

Digestive and liver disease, 2021-09, Vol.53, p.S155-S156

2021

Link zum Volltext

Verfügbarkeit prüfen

Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI

Radiologia medica, 2007-09, Vol.112 (6), p.798-809

2007

Link zum Volltext

Verfügbarkeit prüfen

P.06.15 SAFETY OF ANTI-TNFA THERAPY IN IBD: AN ITALIAN EXPERIENCE

Digestive and liver disease, 2012-03, Vol.44, p.S124-S124

2012

Link zum Volltext

Verfügbarkeit prüfen

P.06.14 ADHERENCE TO ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPIES IN INFLAMMATORY BOWEL DISEASES: EXPERIENCE FROM FOUR REFERRAL ITALIAN CENTERS

Digestive and liver disease, 2012-03, Vol.44, p.S123-S124

2012

Link zum Volltext

Verfügbarkeit prüfen

Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment

Alimentary pharmacology & therapeutics, 1999-11, Vol.13 (11), p.1413-1417

1999

Link zum Volltext

Verfügbarkeit prüfen

Early acid perception in NERD

Diseases of the esophagus, 2011-02, Vol.24 (2), p.127-130

2011

Link zum Volltext

Verfügbarkeit prüfen

P.75 AZATHIOPRINE WITHDRAWAL IN CROHN'S DISEASE: NEVER-ENDING STORY?

Digestive and liver disease, 2010, Vol.42, p.S129-S130

2010

Link zum Volltext

Verfügbarkeit prüfen

P.74 AVAILABLE MEDICAL THERAPIES DO NOT AFFECT DEVELOPMENT OF MAJOR COMPLICATIONS AND NEED FOR SURGERY IN CROHN'S DISEASE: LONG-TERM PROSPECTIVE STUDY ON A POPULATION OF 193 CONSECUTIVE PATIENTS

Digestive and liver disease, 2010, Vol.42, p.S129-S129

2010

Link zum Volltext

Verfügbarkeit prüfen

OC.07.2 BECLOMETASONE DIPROPIONATE AND MESALAZINE ARE EQUALLY EFFECTIVE IN THE TREATMENT OF LYMPHOCYTIC COLITIS

Digestive and liver disease, 2010, Vol.42, p.S87-S87

2010

Link zum Volltext

Verfügbarkeit prüfen

AF.61 PROSPECTIVE, OBSERVATIONAL STUDY OF PROPHYLACTIC VEDOLIZUMAB TREATMENT IN PREVENTING POSTOPERATIVE RECURRENCE (POR) IN HIGH-RISK CROHN’S PATIENTS

Digestive and liver disease, 2021-09, Vol.53, p.S164-S165

2021

Link zum Volltext

Verfügbarkeit prüfen

T04.01.17 USEFULNESS ON INTESTINAL ULTRASOUND IN THE EVALUATION OF COLONIC INFLAMMATION IN PATIENTS WITH

Digestive and liver disease, 2020-10, Vol.52, p.S124

2020

Link zum Volltext

Verfügbarkeit prüfen

MESALAZINE'S ANTI-INFLAMMATORY ACTION THROUGH THE PPARγ IN CELIAC DISEASE

Digestive and liver disease, 2009, Vol.41, p.S91-S92

2009

Link zum Volltext

Verfügbarkeit prüfen

P.02.23 IGG4-RELATED DISEASE MIMICKING CROHN'S DISEASE: A CASE REPORT AND SYSTEMATIC REVIEW OF LITERATURE

Digestive and liver disease, 2018-03, Vol.50 (2), p.e141-e141

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(65)
Life Sciences & Biomedicine
(59)
Science & Technology
(59)
Medical Sciences
(45)
Biological And Medical Sciences
(44)
Male
(40)
Middle Aged
(38)
Female
(37)
Adult
(33)
Gastroenterology & Hepatology
(30)
Aged
(22)
Pharmacology. Drug Treatments
(19)
Gastroenterology And Hepatology
(14)
Gastroenterology. Liver. Pancreas. Abdomen
(13)
Other Diseases. Semiology
(13)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(12)
Hematology
(10)
Intestinal Mucosa - Metabolism
(9)
Aged, 80 And Over
(8)
Immunology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is mesalazine treatment effective in the prevention of diverticulitis? A review

Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

P.09.11 ASSOCIATION BETWEEN COLORECTAL POLYPS AND COLONIC DIVERTICULOSIS

The dyspeptic macrophage 30 years later: An update in the pathogenesis of Crohn's disease

Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation

Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis

P.06.6 SUBTYPES OF CHRONIC GASTRITIS IN PATIENTS WITH COELIAC DISEASE BEFORE AND AFTER GLUTEN-FREE DIET

P.03.10 FUNCTIONAL DYSPEPSIA: IS DUODENAL BIOPSY WORTHWHILE?

Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis

Mesalazine vanishing time from rectal mucosa following its topical administration

P.05.12 COLONIC MUCOSAL ORGAN CULTURE: ITS OPPORTUNISTIC USE TO DETECT CELIAC DISEASE

Short‐chain fatty acid topical treatment in distal ulcerative colitis

AF.41 THE PROGNOSTIC VALUE OF ENDOSCOPIC MAYO SCORE 0 VERSUS 1 IN PATIENTS WITH ULCERATIVE COLITIS IN STEROID-FREE CLINICAL REMISSION: A SYSTEMATIC REVIEW AND METAANALYSIS

Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI

P.06.15 SAFETY OF ANTI-TNFA THERAPY IN IBD: AN ITALIAN EXPERIENCE

P.06.14 ADHERENCE TO ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPIES IN INFLAMMATORY BOWEL DISEASES: EXPERIENCE FROM FOUR REFERRAL ITALIAN CENTERS

Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment

Early acid perception in NERD

P.75 AZATHIOPRINE WITHDRAWAL IN CROHN'S DISEASE: NEVER-ENDING STORY?

P.74 AVAILABLE MEDICAL THERAPIES DO NOT AFFECT DEVELOPMENT OF MAJOR COMPLICATIONS AND NEED FOR SURGERY IN CROHN'S DISEASE: LONG-TERM PROSPECTIVE STUDY ON A POPULATION OF 193 CONSECUTIVE PATIENTS

OC.07.2 BECLOMETASONE DIPROPIONATE AND MESALAZINE ARE EQUALLY EFFECTIVE IN THE TREATMENT OF LYMPHOCYTIC COLITIS

AF.61 PROSPECTIVE, OBSERVATIONAL STUDY OF PROPHYLACTIC VEDOLIZUMAB TREATMENT IN PREVENTING POSTOPERATIVE RECURRENCE (POR) IN HIGH-RISK CROHN’S PATIENTS

T04.01.17 USEFULNESS ON INTESTINAL ULTRASOUND IN THE EVALUATION OF COLONIC INFLAMMATION IN PATIENTS WITH

MESALAZINE'S ANTI-INFLAMMATORY ACTION THROUGH THE PPARγ IN CELIAC DISEASE

P.02.23 IGG4-RELATED DISEASE MIMICKING CROHN'S DISEASE: A CASE REPORT AND SYSTEMATIC REVIEW OF LITERATURE

Suchergebnisse filtern